New hope for hepatitis c: experimental drug shows promise in small trial
NCT ID NCT00621296
First seen Jan 09, 2026 · Last updated Apr 28, 2026 · Updated 18 times
Summary
This early-phase study tested an experimental drug called MP-424 in 15 people with chronic hepatitis C (genotype 1b) who had not taken interferon before. The main goal was to see if the drug could make the virus undetectable 24 weeks after treatment ended, and to check for side effects. The results help guide future research, but the drug is not yet proven as a cure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATITIS C are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Toranomon Hospital
Kawasaki, Takatsu-ku, Japan
Conditions
Explore the condition pages connected to this study.